JAMA:尼古丁贴片vs伐伦克林vs联合尼古丁替代疗法戒烟效果

2016-01-27 MedSci MedSci原创

Timothy B. Baker, Megan E. Piper,et al,Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks.JAMA,January 26, 2016ht

医疗保健中时常需要用到戒烟药物,识别出最有效的药物和导致可预防性死亡的药物十分重要。

研究目的是为了比较伐伦克林、联合尼古丁替代疗法(C-NRT)和尼古丁片的26周戒烟效果。招募了麦迪逊,威斯康星州和威斯康辛州密尔沃基市社区的吸烟者,从2012年5月到11月,进行三组随机的意向性临床治疗试验。

参与者被随机分配为三组,进行12周的开放式戒烟治疗。1.只使用尼古丁片(n = 241);2只使用伐伦克林(包括1个提前戒烟周;n = 424),和3.C-NRT(尼古丁贴片+尼古丁含片;n = 421)。

主要结果是CO定量和26周时自我报道的7天禁烟欲情况。次要结果是CO定量和自我报道的初次戒烟欲望,戒烟延长到26周,和4周,12周,52周的戒烟情况。

结论指出,从成人准备开始戒烟,使用尼古丁片、伐尼克兰、或 C-NRT进行12周的开放实验,在26周时,从生化生平无明显戒烟区别。这个结局质疑了严重吸烟者药物疗法的相对有效性。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1739828, encodeId=66c61e398281c, content=<a href='/topic/show?id=aa7c2569401' target=_blank style='color:#2F92EE;'>#伐伦克林#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25694, encryptionId=aa7c2569401, topicName=伐伦克林)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a834571613, createdName=1179102698_36768937, createdTime=Fri Mar 11 13:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647864, encodeId=98d1164e86465, content=<a href='/topic/show?id=12b24e35524' target=_blank style='color:#2F92EE;'>#尼古丁替代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47355, encryptionId=12b24e35524, topicName=尼古丁替代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a78423523432, createdName=makuansheng, createdTime=Wed Mar 02 13:25:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764144, encodeId=d9781e64144b5, content=<a href='/topic/show?id=844492480bb' target=_blank style='color:#2F92EE;'>#贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92480, encryptionId=844492480bb, topicName=贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f237637156, createdName=12498b37m84暂无昵称, createdTime=Wed May 04 02:25:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663843, encodeId=7d03166384308, content=<a href='/topic/show?id=c5ee4e357e3' target=_blank style='color:#2F92EE;'>#尼古丁贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47357, encryptionId=c5ee4e357e3, topicName=尼古丁贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bfb25689400, createdName=jingyanzhu715_39486109, createdTime=Fri Jun 03 05:25:00 CST 2016, time=2016-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648343, encodeId=0dd11648343ef, content=<a href='/topic/show?id=1b88603298d' target=_blank style='color:#2F92EE;'>#替代疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60329, encryptionId=1b88603298d, topicName=替代疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f1023558367, createdName=skhzy, createdTime=Tue Apr 05 17:25:00 CST 2016, time=2016-04-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1739828, encodeId=66c61e398281c, content=<a href='/topic/show?id=aa7c2569401' target=_blank style='color:#2F92EE;'>#伐伦克林#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25694, encryptionId=aa7c2569401, topicName=伐伦克林)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a834571613, createdName=1179102698_36768937, createdTime=Fri Mar 11 13:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647864, encodeId=98d1164e86465, content=<a href='/topic/show?id=12b24e35524' target=_blank style='color:#2F92EE;'>#尼古丁替代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47355, encryptionId=12b24e35524, topicName=尼古丁替代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a78423523432, createdName=makuansheng, createdTime=Wed Mar 02 13:25:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764144, encodeId=d9781e64144b5, content=<a href='/topic/show?id=844492480bb' target=_blank style='color:#2F92EE;'>#贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92480, encryptionId=844492480bb, topicName=贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f237637156, createdName=12498b37m84暂无昵称, createdTime=Wed May 04 02:25:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663843, encodeId=7d03166384308, content=<a href='/topic/show?id=c5ee4e357e3' target=_blank style='color:#2F92EE;'>#尼古丁贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47357, encryptionId=c5ee4e357e3, topicName=尼古丁贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bfb25689400, createdName=jingyanzhu715_39486109, createdTime=Fri Jun 03 05:25:00 CST 2016, time=2016-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648343, encodeId=0dd11648343ef, content=<a href='/topic/show?id=1b88603298d' target=_blank style='color:#2F92EE;'>#替代疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60329, encryptionId=1b88603298d, topicName=替代疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f1023558367, createdName=skhzy, createdTime=Tue Apr 05 17:25:00 CST 2016, time=2016-04-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1739828, encodeId=66c61e398281c, content=<a href='/topic/show?id=aa7c2569401' target=_blank style='color:#2F92EE;'>#伐伦克林#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25694, encryptionId=aa7c2569401, topicName=伐伦克林)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a834571613, createdName=1179102698_36768937, createdTime=Fri Mar 11 13:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647864, encodeId=98d1164e86465, content=<a href='/topic/show?id=12b24e35524' target=_blank style='color:#2F92EE;'>#尼古丁替代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47355, encryptionId=12b24e35524, topicName=尼古丁替代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a78423523432, createdName=makuansheng, createdTime=Wed Mar 02 13:25:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764144, encodeId=d9781e64144b5, content=<a href='/topic/show?id=844492480bb' target=_blank style='color:#2F92EE;'>#贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92480, encryptionId=844492480bb, topicName=贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f237637156, createdName=12498b37m84暂无昵称, createdTime=Wed May 04 02:25:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663843, encodeId=7d03166384308, content=<a href='/topic/show?id=c5ee4e357e3' target=_blank style='color:#2F92EE;'>#尼古丁贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47357, encryptionId=c5ee4e357e3, topicName=尼古丁贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bfb25689400, createdName=jingyanzhu715_39486109, createdTime=Fri Jun 03 05:25:00 CST 2016, time=2016-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648343, encodeId=0dd11648343ef, content=<a href='/topic/show?id=1b88603298d' target=_blank style='color:#2F92EE;'>#替代疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60329, encryptionId=1b88603298d, topicName=替代疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f1023558367, createdName=skhzy, createdTime=Tue Apr 05 17:25:00 CST 2016, time=2016-04-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1739828, encodeId=66c61e398281c, content=<a href='/topic/show?id=aa7c2569401' target=_blank style='color:#2F92EE;'>#伐伦克林#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25694, encryptionId=aa7c2569401, topicName=伐伦克林)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a834571613, createdName=1179102698_36768937, createdTime=Fri Mar 11 13:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647864, encodeId=98d1164e86465, content=<a href='/topic/show?id=12b24e35524' target=_blank style='color:#2F92EE;'>#尼古丁替代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47355, encryptionId=12b24e35524, topicName=尼古丁替代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a78423523432, createdName=makuansheng, createdTime=Wed Mar 02 13:25:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764144, encodeId=d9781e64144b5, content=<a href='/topic/show?id=844492480bb' target=_blank style='color:#2F92EE;'>#贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92480, encryptionId=844492480bb, topicName=贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f237637156, createdName=12498b37m84暂无昵称, createdTime=Wed May 04 02:25:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663843, encodeId=7d03166384308, content=<a href='/topic/show?id=c5ee4e357e3' target=_blank style='color:#2F92EE;'>#尼古丁贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47357, encryptionId=c5ee4e357e3, topicName=尼古丁贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bfb25689400, createdName=jingyanzhu715_39486109, createdTime=Fri Jun 03 05:25:00 CST 2016, time=2016-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648343, encodeId=0dd11648343ef, content=<a href='/topic/show?id=1b88603298d' target=_blank style='color:#2F92EE;'>#替代疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60329, encryptionId=1b88603298d, topicName=替代疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f1023558367, createdName=skhzy, createdTime=Tue Apr 05 17:25:00 CST 2016, time=2016-04-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1739828, encodeId=66c61e398281c, content=<a href='/topic/show?id=aa7c2569401' target=_blank style='color:#2F92EE;'>#伐伦克林#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25694, encryptionId=aa7c2569401, topicName=伐伦克林)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a834571613, createdName=1179102698_36768937, createdTime=Fri Mar 11 13:25:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647864, encodeId=98d1164e86465, content=<a href='/topic/show?id=12b24e35524' target=_blank style='color:#2F92EE;'>#尼古丁替代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47355, encryptionId=12b24e35524, topicName=尼古丁替代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a78423523432, createdName=makuansheng, createdTime=Wed Mar 02 13:25:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764144, encodeId=d9781e64144b5, content=<a href='/topic/show?id=844492480bb' target=_blank style='color:#2F92EE;'>#贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92480, encryptionId=844492480bb, topicName=贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f237637156, createdName=12498b37m84暂无昵称, createdTime=Wed May 04 02:25:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663843, encodeId=7d03166384308, content=<a href='/topic/show?id=c5ee4e357e3' target=_blank style='color:#2F92EE;'>#尼古丁贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47357, encryptionId=c5ee4e357e3, topicName=尼古丁贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bfb25689400, createdName=jingyanzhu715_39486109, createdTime=Fri Jun 03 05:25:00 CST 2016, time=2016-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648343, encodeId=0dd11648343ef, content=<a href='/topic/show?id=1b88603298d' target=_blank style='color:#2F92EE;'>#替代疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60329, encryptionId=1b88603298d, topicName=替代疗法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f1023558367, createdName=skhzy, createdTime=Tue Apr 05 17:25:00 CST 2016, time=2016-04-05, status=1, ipAttribution=)]

相关资讯

JAMA:伐尼克兰结合尼古丁贴片可提高戒烟率

据7月9日发表在《美国医学会杂志》上的一则研究披露,对在用药6个月时实现烟草戒断来说,将戒烟药伐尼克兰与尼古丁替代疗法相结合比单用伐尼克兰更有效。 将行为疗法与药物治疗相结合对协助吸烟者戒烟具有得到证明的裨益。根据文章的背景资料,将尼古丁替代疗法(NRT)与伐尼克兰结合使用是一种建议的可改善戒断烟瘾的治疗方法,但其有效性是不确定的。 南非开普敦斯坦陵布什大学的 Coenraad Koegelenb